Search PubMed⌕ Search

Biomedical subjects

O Langer

Publications and source records attributed to O Langer.

At least 55 records · Page 3Linked to original sources
PubMed1996

Perinatal outcome and the type and number of maneuvers in shoulder dystocia.

OBJECTIVES: To ascertain the type and order of maneuvers that should be used for the treatment of shoulder dystocia, and to determine its correlation with perinatal outcome. METHODS: We reviewed all consecutive cases of shoulder dystocia from January 1986 to August 1994 in our institution to obtain the type, order and number of maneuvers used for delivery. Patients were stratified by the number of maneuvers required for delivery. Outcome parameters included cord pH, Apgar score, neonatal trauma (Erb's palsy and fracture), and maternal trauma. RESULTS: The incidence of shoulder dystocia was 0.7% (39,280 total vaginal deliveries). Use of only two maneuvers, McRoberts and suprapubic pressure, resulted in resolution in 58% of cases. The addition of the Woods screw maneuver and/or delivery of the posterior arm was sufficient in all remaining cases. The rates of neonatal palsy and fracture, and maternal four-degree laceration, increased with the number of maneuvers. CONCLUSIONS: The McRoberts maneuver and suprapubic pressure should be first-line treatment for shoulder dystocia. More difficult and damaging maneuvers such as Woods screw and delivery of the posterior arm may be reserved for refractory cases. Additional maneuvers are rarely necessary for delivery. The number of maneuvers may serve as a measure of the severity of the shoulder dystocia.

Adult↗
PubMed1996

Management of gestational diabetes mellitus.

This article addresses management of gestational diabetes in a two part fashion. It discusses the pathophysiology and pathogenesis of diabetes and outlines the contemporary management approach for gestational diabetes in the 1990s.

Blood Glucose↗
PubMed1996

Fuel metabolism in deviant fetal growth in offspring of diabetic women.

Fetal growth and development from its very first stages of intrauterine life is significantly influenced by the metabolic environment in which the conceptus develops. Maternal disease states such as gestational diabetes and hypertensive pregnancy, representing maternal conditions involved in extremes of impaired fetal growth (macrosomia versus growth restriction), can serve as excellent examples of the various factors that are involved in intrauterine growth.

Diabetes, Gestational↗
PubMed1996

Maternal-fetal glucose metabolism and fetal growth retardation. Is there an association?

OBJECTIVE: To test the hypothesis that in normotensive pregnancies decreased maternal glucose response leads to relative fetal hypoglycemia and hypoinsulinemia, which result in delayed fetal growth. STUDY DESIGN: We enrolled patients with and without risk factors for growth retardation. Each underwent an oral glucose tolerance test with both glucose and insulin evaluation. Cord blood was obtained for glucose and insulin evaluation. RESULTS: The normotensive pregnancies at risk had lower maternal glucose levels (index, 91 vs. 116 mg/dL; P < .05), a trend toward lower maternal insulin levels (index, 398 vs. 483 muIU/mL; P = NS) and normal maternal insulin/glucose ratios. We found no differences, however, in the fetal metabolic parameters (glucose 83 vs. 78 mg/dL, insulin 17 vs. 24 muIU/mL; P = NS). CONCLUSION: Maternal glucose metabolism is altered in nonhypertensive pregnancies, with a risk of delayed fetal growth; however, the fetal glucose response may remain normal in the face of fetal growth retardation.

Adolescent↗
PubMed1995

Low-dose versus high-dose oxytocin augmentation of labor--a randomized trial.

OBJECTIVE: Our purpose was to compare the efficacy and safety of low-dose versus high-dose oxytocin regimens in the augmentation of labor. STUDY DESIGN: Three hundred ten term pregnancies requiring augmentation of labor underwent randomization to receive either a low-dose or high-dose oxytocin augmentation regimen. Maternal demographics, labor-delivery data, and neonatal outcome were compared. RESULTS: The high-dose oxytocin group had a significantly lower cesarean section rate, regardless of parity (10.4% vs 25.7%, p < 0.001), with no differences in maternal complications and neonatal outcomes. The time needed to correct the labor abnormality was also significantly decreased (1.24 +/- 1.4 hours vs 3.12 +/- 1.6 hours, p < 0.001) in the high-dose group. CONCLUSIONS: The use of high-dose oxytocin regimen benefits both nulliparous and multiparous women requiring labor augmentation by significantly lowering both the time necessary to correct the labor abnormality and the need for cesarean section.

Adolescent↗
PubMed1995

Are labor abnormalities more common in shoulder dystocia?

OBJECTIVE: Our objective was to determine the association between labor abnormalities and shoulder dystocia. STUDY DESIGN: All consecutive cases of shoulder dystocia from January 1986 to August 1994 were reviewed (n = 276). For purposes of comparison a control group of vaginally delivered patients was randomly selected in a 2:1 ratio (n = 600). Charts were reviewed for demographic information, labor and delivery events, and neonatal outcome. RESULTS: Labor abnormalities were comparable in the shoulder dystocia and control groups, both in the active phase and in the second stage. When patients with diabetes and those with macrosomic infants were analyzed separately, no significant differences in labor abnormalities were identified. The rate of operative vaginal delivery was significantly higher in the shoulder group, and one third of the operative deliveries were midpelvic. In addition, the induction rate was higher in the shoulder group. CONCLUSIONS: Our data suggest that labor abnormalities may not serve as clinical predictors for subsequent development of shoulder dystocia, thus emphasizing the unpredictability of this condition.

Adult↗
PubMed1995

Glucose tolerance test periodicity: the effect of glucose loading.

OBJECTIVE: To test the hypothesis that glucose abnormality, as shown by glucose tolerance test (GTT) periodicity, is not affected by different glucose loads, allowing for the identification of gestational diabetes mellitus (GDM) under varying glucose challenges. METHODS: Eighty subjects were tested by multiple GTTs 1 week apart. Each woman served as her own control, undergoing a standard 3-hour, 100-g GTT; then, half of the subject group randomly underwent a 50-g and the other half a 75-g, 2-hour GTT. Subjects were classified using National Diabetes Data Group thresholds for the 100-g GTT. Those with two or more abnormal values were classified as gestational diabetic (GDM group); the rest of the women were considered to be nondiabetic. The projected time for the GTT to revert to fasting value, GTT periodicity, was then determined for each glucose load in the GDM and nondiabetic groups. RESULTS: All glucose values for the nondiabetic group were significantly lower at 1 and 2 hours than those for the GDM group, regardless of the glucose load (P < .04). There was a statistically significant difference within the GDM and nondiabetic groups between glucose values of the 100- and 50-g GTTs at 1 hour (P < .02) and between all loads at 2 hours (P < .04). The GTT periodicity for the 3-hour, 100-g test was significantly longer for patients with GDM, as shown previously (5.6 +/- 1.9 versus 3.2 +/- 1.7 hours, P < .0001). In addition, similar values were found for nondiabetic and GDM subjects for the 75-g (5.1 +/- 2 versus 3.6 +/- 1.8 hours, P < .04), but not the 50-g load (2.2 +/- .6 versus 1.34 +/- .8 hours, P < .01). CONCLUSION: Glucose tolerance test periodicity will identify subjects with GDM regardless of GTT load because the physiologic disturbance of glucose level measured by this time period remains comparably longer than in normal subjects. We speculate that the relatively shorter cycle of the 50-g load may reflect an insufficient challenge to pancreatic function.

Adult↗
PubMed1995

The effect of maternal obesity on the accuracy of fetal weight estimation.

OBJECTIVE: To determine if maternal obesity affects the accuracy of either clinical or sonographic fetal weight estimations. METHODS: In a year-long study, 998 singleton pregnancies of 26-43 weeks' gestation underwent both clinical (Leopold) and sonographic (Shepard and Hadlock) fetal weight estimation within 5 days of delivery (mean 1.1, 95% confidence interval 1.0-1.3). Patients were stratified into four different groups based on increasing maternal body mass index (BMI): underweight (less than 19.8), normal weight (19.8-26.0), overweight (26.1-29.0), and obese (more than 29.0). The various estimations of fetal weight were compared with actual birth weight, and the mean absolute percent error was calculated for each specific method and analyzed among the four BMI groups. RESULTS: For each method of weight estimation, there was no difference (specifically, no increase) in the magnitude of the absolute percent error with increasing maternal obesity. Regardless of maternal size, almost half of the weight predictions were within 5% of the actual birth weight. CONCLUSION: Increasing maternal obesity does not alter or decrease the accuracy of either clinical or sonographic fetal weight estimations. Therefore, fetal weight predictions provide equally accurate and valid guidelines for determining management decisions in women, regardless of body size.

Body Mass Index↗
PubMed1995

Efficiency of lower threshold criteria for the diagnosis of gestational diabetes.

OBJECTIVES: To determine the incidence of adverse outcome in normal untreated gravidas with minimal hyperglycemia, classified as having gestational diabetes mellitus (GDM) by threshold criteria lower than current standards; to determine how efficient the different criteria are in identifying infants at risk for morbidity; and to explore the pathophysiology of minimal hyperglycemia using the glucose tolerance test (GTT) periodicity concept. METHODS: Seven hundred eight subjects considered nondiabetic by current ACOG criteria were reclassified by the criteria of Coustan (fasting 95, 1 hour 180, 2 hours 155, and 5 hours 140 mg/dL), Sacks (96, 172, 152, and 131 mg/dL), or Langer (at least one abnormal ACOG value). Glucose tolerance test periodicity, the incidence of large for gestational age (LGA) neonates, and macrosomia were then determined for each gravida diagnosed as having GDM by these criteria. RESULTS: Both Coustan and Langer criteria identified a significantly greater incidence of LGA infants compared with non-GDM (23.6 and 25.3%, respectively, versus 14%, P < .05), and identified them as efficiently as current criteria, approximately one LGA infant for every four GDM subjects treated. The incidence of LGA did not differ between the Sacks GDM and non-GDM groups. Glucose tolerance test periodicity for newly diagnosed GDM gravidas was significantly longer than non-GDM for Coustan and Langer criteria (3.9 and 4.06 versus 3.3 hours, P < .01) but not for the Sacks criteria. CONCLUSION: Using lower threshold criteria to diagnose GDM identified morbidity at an incidence and efficiency comparable to current standards. These newly diagnosed GDM gravidas had abnormal GTT characteristics, with each group exceeding the 3.5-hour GTT periodicity limit previously found for nondiabetic gravidas. Sack's conversion of existing standards may be too low to efficiently identify pregnant subjects at risk for increased morbidity.

Adult↗
PubMed1995

Antenatal bleeding and fetal heart rate.

Objective of the paper was to determine the fetal heart rate (FHR) changes that occur in preterm fetuses whose mothers have suffered antepartum bleeding, versus uncomplicated controls. Over a 12-year span, 91 patients with significant antenatal bleeding (bleeding requiring inhospital observation) were examined and compared to 75 controls with uncomplicated normal pregnancies. None of the women were in labor and all were evaluated at 25-37 weeks' gestation. Excluded were: patients with any other complication (i.e., premature rupture of membranes, intrauterine growth retardation, diabetes, hypertension, collagen vascular disease, postuterine surgery, substance abuse and twins). Analysis of the FHR tracings included baseline heart rate, long-term FHR variability, and number and amplitude of FHR accelerations in 20-min segments. There was no difference in baseline heart rate in the preterm fetuses of pregnancies complicated by antepartum bleeding versus controls. However, the parameters associated with FHR reactivity (number of accelerations in 20 min, and amplitude of accelerations) were higher to a statistically significant degree in fetuses of pregnancies complicated by antenatal bleeding than in controls. Fetuses of mothers suffering antenatal bleeding exhibited significant higher rates of reactive FHR patterns at earlier gestational ages than did controls. In conclusion, there is a significant increase in FHR reactivity in pregnancies in which significant antenatal bleeding occurs, suggesting a probable acceleration in fetal central nervous system maturation in these fetuses.

Case-Control Studies↗
PubMed1995

Variations in oral glucose tolerance tests: the 100- versus 75-g controversy.

This study compared the results of a 75-g, 3-hour oral glucose tolerance test with those of a traditional 100-g oral glucose tolerance test. Thirty-two pregnant women participated in the study. Each patient served as her own control, undergoing both a 100- and a 75-g oral glucose tolerance test within 1 week. Despite a strong positive correlation between the results of the two tests, the 1-, 2-, and 3-hour glucose values of the 100-g glucose load were significantly higher than the comparable values of the 75-g oral glucose tolerance test. Sixteen of 32 women were diagnosed as having gestational diabetes mellitus using the National Diabetes Data Group criteria and the 100-g oral glucose tolerance test, whereas only 6 of these 16 women would have been identified with the 75-g oral glucose tolerance test. If data from one test are to be compared with the other, new thresholds of glucose abnormality need to be developed.

Administration, Oral↗
PubMed1995

Cultural diversity as a factor in self-monitoring blood glucose in gestational diabetes.

The routine use of self-monitoring of capillary blood glucose by pregnant diabetic patients currently provides the basis for both clinical management and ongoing investigation. Strategies must therefore be developed to ensure that these data are reliable and accurately reported by patients and are not influenced by diverse socioeconomic levels or varied geographic locations. To explore this issue, we used glucose reflectance meters with a memory microchip capable of storing up to 440 consecutive blood glucose determinations. Two diverse groups of women from Texas and New York who had gestational diabetes performed self-monitoring of blood glucose from diagnosis until delivery. Both groups recorded their blood glucose results daily in a logbook. The reporting performance of all the participating subjects resulted in an actual compliance rate of 60% to 70% of testings required of the patients. Comparison of African-American, Mexican-American, and white populations revealed no significant differences in patient performance or compliance. Moreover, no differences were found between the groups at different geographic locations (New York, Texas) in patients' willingness and ability to comply with the regimen of self-monitoring blood glucose. These findings suggest that the use of memory reflectance meters, in conjunction with patient education and positive interaction between patient and care provider, will result in high patient compliance regardless of socioeconomic level or ethnic diversity.

Adult↗
PubMed1995

Outcome of amniotic fluid analysis and neonatal respiratory status in diabetic and nondiabetic pregnancies.

OBJECTIVE: To evaluate the likelihood of mature or immature amniotic fluid analysis and subsequent presence or absence of neonatal pulmonary disease in a large population of diabetic and nondiabetic pregnancies. STUDY DESIGN: Six hundred sixty-eight pregnancies that delivered within seven days of phosphatidylglycerol (PG) and lecithin/sphingomyelin ratio (L/S) testing were analyzed. (PG testing was by Amniostat-FLM and L/S testing by a modified Gluck technique.) Neonatal respiratory outcome and amniocentesis results were stratified by maternal diabetes status and gestational age for comparison. We determined the likelihood of finding correctly mature and correctly immature amniotic fluid analysis for each gestational age category. RESULTS: We found high rates of incorrectly immature results for PG (53%) and L/S (21%) preterm and for PG at term (20%). Diabetic and nondiabetic pregnancies did not differ. CONCLUSION: Population-based information on the a priori chances of amniotic fluid and neonatal pulmonary outcome in diabetic and nondiabetic pregnancies is given for use in determining the utility of amniotic fluid analysis in individual clinical settings.

Amniotic Fluid↗
PubMed1994

Comparative placental transport of oral hypoglycemic agents in humans: a model of human placental drug transfer.

OBJECTIVE: This study compares the human placental transport of glyburide, glipizide, chlorpropamide, and tolbutamide. STUDY DESIGN: The recirculating single cotyledon human placenta model tested maternal-to-fetal transport in term placentas perfused immediately after delivery. Drug levels were measured by high-performance liquid chromatography and liquid scintillation spectrometry, and transport rates were calculated by comparing maternal and fetal concentrations. RESULTS: The transport of these substances differed significantly over a tenfold range (analysis of variance, p < 0.0008). A significant association exists by multiple linear regression between drug transfer and molecular weight, dissociation constant, and the octanol-water partition coefficient (R2 = 0.91, p < 0.0001). CONCLUSIONS: There is significant variability in human placental transfer rates of the oral hypoglycemics, which strongly correlates with molecular properties. These data suggest that less fetal exposure may occur with second-generation sulfonylureas and anticipate that regression models may be useful in selecting agents that minimize placental transport to the fetus.

Administration, Oral↗
PubMed1994

Use of a more physiologic oral glucose solution during screening for gestational diabetes mellitus.

OBJECTIVES: We sought to compare in pregnant women deviations in glucose values, insulin values, and the occurrence of side effects between a "standard" 50 gm oral glucose solution (50 gm of glucose in 150 ml of fluid, 1.85 mol/L) versus a modified "physiologic" 50 gm oral glucose solution (50 gm of glucose in 450 ml of fluid, 0.62 mol/L) as a screening test for gestational diabetes mellitus. STUDY DESIGN: A total of 132 pregnant women underwent (1) a standard 50 gm, 1-hour oral glucose screening test, (2) a 50 gm, 1-hour oral glucose screening test using the modified solution, and (3) a 3-hour oral glucose tolerance test (with 100 gm of glucose in 300 ml of fluid, 1.85 mol/L). RESULTS: Compared with the "standard" regimen, both glucose and insulin values were significantly higher in the "modified" regimen 30 minutes after ingestion, indicating a more rapid absorption of glucose. Nausea and vomiting were greatly decreased with the modified glucose solution. The 1-hour glucose values were not statistically different. CONCLUSIONS: A more dilute, more palatable oral glucose solution can be used to screen for gestational diabetes mellitus, yielding more accurate results and eliminating unpleasant side effects.

Administration, Oral↗
PubMed1994

The effect of clinical chorioamnionitis on cord blood gas at term.

OBJECTIVE: We sought to determine the effect of clinical chorioamnionitis on cord blood gas values in term pregnancies not complicated by any other disease. STUDY DESIGN: 2200 consecutive deliveries were studied. Following exclusion of twins, non-viable malformations and stillbirths, as well as mothers with high-risk pregnancy diseases--i.e. hypertension, diabetes, preterm labor, third-trimester bleeding, IUGR, postdates, oligohydramnios, i.v. drug abused, decreased fetal movement, maternal viral infection, UTI or pneumonia (n = 897)--two groups of patients remained: term pregnancies complicated only by clinical chorioamnionitis (n = 81) and uncomplicated term pregnancies (n = 1246). RESULTS: Evaluation of mean cord blood gas values revealed a significant difference in pH, PO2, PCO2 and BE values, with the infants of mothers with clinical chorioamnionitis having lower pH values (7.23 +/- 0.07 vs. 7.28 +/- 0.07). However, evaluating the independent effect of chorioamnionitis on arterial cord blood pH (using a logistic regression model) showed that clinical chorioamnionitis, by itself, did not contribute to this change in arterial cord blood pH. CONCLUSION: Chorioamnionitis was neither the explanation nor the cause for differences in arterial cord blood pH found between the two groups in our study. In cases of chorioamnionitis, these differences were attributed to other factors, such as length of labor, mode of delivery, method of delivery and presence of meconium.

Adult↗